Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice: Putative effect of antiinflammatory cytokines

NeuroImmunoModulation

Volumn 13, Issue 2, 2006, Pages 114-121

  Gay, Jérôme ^a   Kokkotou, Efi ^b   O'Brien, Michael ^c   Pothoulakis, Charalabos ^b   Karalis, Katia P ^a,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^d BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Interleukin 6; Transgenic mouse; Trinitrobenzene sulfonic acid colitis; Tumor growth factor

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; RECEPTOR ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; BEHAVIOR CHANGE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE MODEL; ENTERITIS; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; HISTOLOGY; INTESTINE EPITHELIUM; INTESTINE INJURY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WEIGHT CHANGE; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; CHEMOTAXIS, LEUKOCYTE; COLITIS; COLON; DISEASE MODELS, ANIMAL; EATING; FEMALE; INTERLEUKIN-10; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TRANSFORMING GROWTH FACTOR BETA; TRINITROBENZENESULFONIC ACID; UP-REGULATION;

EID: 33751307635     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096656     Document Type: Article

References (44)

1. Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205.
2. Podolsky DK: Inflammatory bowel disease. N Engl J Med 2002;347:417-429.
3. Papadakis KA, Targan SR: The role of chemokines and chemokine receptors in mucosal inflammation. Inflamm Bowel Dis 2000;6:303-313.
4. Reimund JM, Wittersheim C, Dumont S, et al: Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol 1996;16:144-150.
5. Brown KA, Back SJ, Ruchelli ED, et al: Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients. Am J Gastroenterol 2002;97:2603-2608.
6. Grottrup-Wolfers E, Moeller J, Karbach U, et al: Elevated cell-associated levels of interleukin 1β and interleukin 6 in inflamed mucosa of inflammatory bowel disease. Eur J Clin Invest 1996;26:115-122.
7. Ito H, Hirotani T, Yamamoto M, et al: Anti-IL-6 receptor monoclonal antibody inhibits leukocyte recruitment and promotes T-cell apoptosis in a murine model of Crohn's disease. J Gastroenterol 2002;37(suppl 14):56-61.
8. Atreya R, Mudter J, Finotto S, et al: Blockade of interleukin 6 transsignalling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med 2000;6:583-588.
9. Kopf M, Baumann H, Freer G, et al: Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994;368:339-342.
10. Schieffer B, Selle T, Hilfiker A, et al: Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation 2004;110:3493-3500.
11. Hata H, Sakaguchi N, Yoshitomi H, et al: Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 2004;114:582-588.
12. Meng ZH, Dyer K, Billiar TR, et al: Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock. Am J Physiol Cell Physiol 2001;280:C343-C351.
13. Naito Y, Takagi T, Uchiyama K, et al: Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice. Int J Mol Med 2004;14:191-196.
14. Dieleman LA, Ridwan BU, Tennyson GS, et al: Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994;107:1643-1652.
15. Strober W, Fuss IJ, Blumberg RS: The immunology of mucosal models of inflammation. Annu Rev Immunol 2002;20:495-549.
16. Fabia R, Ar'Rajab A, Johansson ML, et al: Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat. Digestion 1993;54:248-255.
17. Bradley PP, Priebat DA, Christensen RD, et al: Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-209.
18. Venihaki M, Dikkes P, Carrigan A, et al: Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J Clin Invest 2001;108:1159-1166.
19. Rozen SS, H: Primer3 on the WWW for general users and for biologist programmers; in Krawetz SA, Misener S (eds): Bioinformatics: Methods and Protocols. Methods in Molecular Biology. Totowa, Humana Press, 2000, pp 365-386.
20. Wallenius V, Wallenius K, Ahren B, et al: Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002;8:75-79.
21. Fattori E, Cappelletti M, Costa P, et al: Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 1994;180:1243-1250.
22. Bopst M, Haas C, Car B, et al: The combined inactivation of tumor necrosis factor and interleukin-6 prevents induction of the major acute phase proteins by endotoxin. Eur J Immunol 1998;28:4130-4137.
23. El-Haj T, Poole S, Farthing MJ, et al: Anorexia in a rat model of colitis: interaction of interleukin-1 and hypothalamic serotonin. Brain Res 2002;927:1-7.
24. Ballinger AB, Camacho-Hubner C, Croft NM: Growth failure and intestinal inflammation. QJM 2001;94:121-125.
25. Grunfeld C, Feingold KR: Regulation of lipid metabolism by cytokines during host defense. Nutrition 1996;12:S24-S26.
26. Sarraf P, Frederich RC, Turner EM, et al: Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 1997;185:171-175.
27. Gershenwald JE, Fong YM, Fahey TJ 3rd, et al: Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci USA 1990;87:4966-4970.
28. Burgess W, Gheusi G, Yao J, et al: Interleukin-1β-converting enzyme-deficient mice resist central but not systemic endotoxin-induced anorexia. Am J Physiol 1998;274:R1829-R1833.
29. Faggioni R, Fantuzzi G, Fuller J, et al: IL-1β mediates leptin induction during inflammation. Am J Physiol 1998;274:R204-R208.
30. Suzuki A, Hanada T, Mitsuyama K, et al: CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med 2001;193:471-481.
31. Beck PL, Rosenberg IM, Xavier RJ, et al: Transforming growth factor-beta mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells. Am J Pathol 2003;162:597-608.
32. Sato Y, Ohshima T, Kondo T: Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Biochem Biophys Res Commun 1999;265:194-199.
33. Tracey KJ, Cerami A: Cachectin/tumor necrosis factor and other cytokines in infectious disease. Curr Opin Immunol 1989;1:454-461.
34. Lamblin C, Desreumaux P, Colombel JF, et al: Overexpression of IL-10 mRNA in gut mucosa of patients with allergic asthma. J Allergy Clin Immunol 2001;107:739-741.
35. Asadullah K, Sterry W, Volk HD: Interleukin-10 therapy - review of a new approach. Pharmacol Rev 2003;55:241-269.
36. Lee CG, Homer RJ, Cohn L, et al: Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J Biol Chem 2002;277:35466-35474.
37. Yang J, Zhang X, Li Y, et al: Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-β1 signaling. J Am Soc Nephrol 2003;14:3167-3177.
38. Gotteland M, Lopez M, Munoz C, et al: Local and systemic liberation of proinflammatory cytokines in ulcerative colitis. Dig Dis Sci 1999;44:830-835.
39. Ishiguro Y: Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis. J Gastroenterol 1999;34:66-74.
40. Woywodt A, Ludwig D, Neustock P, et al: Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999;11:267-276.
41. Raab Y, Hallgren R, Gerdin B: Enhanced intestinal synthesis of interleukin-6 is related to the disease severity and activity in ulcerative colitis. Digestion 1994;55:44-49.
42. Natale L, Piepoli AL, De Salvia MA, et al: Interleukins 1β and 6 induce functional alteration of rat colonic motility: an in vitro study. Eur J Clin Invest 2003;33:704-712.
43. Leon LR, White AA, Kluger M: Role of IL-6 and TNF in thermoregulation and survival during sepsis. Am J Physiol 1998;275:R269-R277.
44. van Lettow M, van der Meer JW, West CE, van Crevel R, Semba RD: Interleukin-6 and human immunodeficiency virus load, but not plasma leptin concentration, predict anorexia and wasting in adults with pulmonary tuberculosis in Malawi. J Clin Endocrinol Metab 2005;90:4771-4776.